114 related articles for article (PubMed ID: 8410291)
21. Assessment of adrenergic neuron function altered with progression of heart failure.
Wakasugi S; Inoue M; Tazawa S
J Nucl Med; 1995 Nov; 36(11):2069-74. PubMed ID: 7472601
[TBL] [Abstract][Full Text] [Related]
22. In vitro and animal validation of bromine-76-bromodeoxyuridine as a proliferation marker.
Bergström M; Lu L; Fasth KJ; Wu F; Bergström-Pettermann E; Tolmachev V; Hedberg E; Cheng A; Långström B
J Nucl Med; 1998 Jul; 39(7):1273-9. PubMed ID: 9669410
[TBL] [Abstract][Full Text] [Related]
23. Feasibility of myocardial PET imaging using a benzylguanidine analog: meta-(3-[
Woo SK; Moon BS; Kim BS; Kim MH; Lee YJ; Jung JH; Lee KC; Seo Y; Kim W; Lim SM; Lee BC; Kim SE
Nucl Med Biol; 2018 Jun; 61():63-70. PubMed ID: 29783202
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and preliminary evaluation of carbon-11-meta-hydroxyephedrine: a false transmitter agent for heart neuronal imaging.
Rosenspire KC; Haka MS; Van Dort ME; Jewett DM; Gildersleeve DL; Schwaiger M; Wieland DM
J Nucl Med; 1990 Aug; 31(8):1328-34. PubMed ID: 2384800
[TBL] [Abstract][Full Text] [Related]
25. Adriamycin, congestive cardiomyopathy, and metaiodobenzylguanidine.
Strashun A
J Nucl Med; 1992 Feb; 33(2):215-22. PubMed ID: 1732443
[No Abstract] [Full Text] [Related]
26. Clinical evaluation of carbon-11-phenylephrine: MAO-sensitive marker of cardiac sympathetic neurons.
Raffel DM; Corbett JR; del Rosario RB; Gildersleeve DL; Chiao PC; Schwaiger M; Wieland DM
J Nucl Med; 1996 Dec; 37(12):1923-31. PubMed ID: 8970507
[TBL] [Abstract][Full Text] [Related]
27. Development of a kit-form analog of metaiodobenzylguanidine.
Lee H; Inbasekaran MN; Wieland DM; Sherman PS; Fisher SJ; Mangner TJ; Rogers WL; Clinthorne NH
J Nucl Med; 1986 Feb; 27(2):256-67. PubMed ID: 3712043
[TBL] [Abstract][Full Text] [Related]
28. Measuring acute changes in adrenergic nerve activity of the heart in the living animal.
Sisson JC; Bolgos G; Johnson J
Am Heart J; 1991 Apr; 121(4 Pt 1):1119-23. PubMed ID: 2008834
[TBL] [Abstract][Full Text] [Related]
29. Cardiac retention of PET neuronal imaging agent LMI1195 in different species: impact of norepinephrine uptake-1 and -2 transporters.
Yu M; Bozek J; Kagan M; Guaraldi M; Silva P; Azure M; Onthank D; Robinson SP
Nucl Med Biol; 2013 Jul; 40(5):682-8. PubMed ID: 23601914
[TBL] [Abstract][Full Text] [Related]
30. Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia.
Langer A; Freeman MR; Josse RG; Armstrong PW
J Am Coll Cardiol; 1995 Mar; 25(3):610-8. PubMed ID: 7860904
[TBL] [Abstract][Full Text] [Related]
31. Uptake and washout of I-123-MIBG in neuronal and non-neuronal sites in rat hearts: relationship to renal clearance.
Arbab AS; Koizumi K; Araki T
Ann Nucl Med; 1996 May; 10(2):211-7. PubMed ID: 8800450
[TBL] [Abstract][Full Text] [Related]
32. Modulation of left ventricular iodine-125-MIBG accumulation in cardiomyopathic Syrian hamsters using the renin-angiotensin system.
Takatsu H; Uno Y; Fujiwara H
J Nucl Med; 1995 Jun; 36(6):1055-61. PubMed ID: 7769428
[TBL] [Abstract][Full Text] [Related]
33. Regional adrenergic denervation in ventricular fibrillation without apparent heart disease.
Lekakis J; Antoniou A; Prassopoulos V; Kostamis P; Moulopoulos S
Am Heart J; 1994 Apr; 127(4 Pt 1):951-3. PubMed ID: 8154444
[No Abstract] [Full Text] [Related]
34. PET and SPET tracers for mapping the cardiac nervous system.
Langer O; Halldin C
Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):416-34. PubMed ID: 12002720
[TBL] [Abstract][Full Text] [Related]
35. [123I-MIBG myocardial scintigraphical analysis in patients with and without autonomic disorder].
Hakusui S; Yasuda T; Yanagi T; Takahashi A; Hasegawa Y; Inoue M
Rinsho Shinkeigaku; 1994 Apr; 34(4):402-4. PubMed ID: 8026141
[TBL] [Abstract][Full Text] [Related]
36. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts--implications for clinical studies.
Dae MW; De Marco T; Botvinick EH; O'Connell JW; Hattner RS; Huberty JP; Yuen-Green MS
J Nucl Med; 1992 Aug; 33(8):1444-50. PubMed ID: 1634934
[TBL] [Abstract][Full Text] [Related]
37. Positron emission tomographic investigations of central muscarinic cholinergic receptors with three isomers of [76Br]BrQNP.
Strijckmans V; Bottlaender M; Luo H; Ottaviani M; McPherson DW; Loc'h C; Fuseau C; Knapp FF; Mazière B
Eur J Nucl Med; 1997 May; 24(5):475-82. PubMed ID: 9142726
[TBL] [Abstract][Full Text] [Related]
38. Discrepant uptake of the radiolabeled norepinephrine analogues hydroxyephedrine (HED) and metaiodobenzylguanidine (MIBG) in rat hearts.
Rischpler C; Fukushima K; Isoda T; Javadi MS; Dannals RF; Abraham R; Wahl R; Bengel FM; Higuchi T
Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):1077-83. PubMed ID: 23539177
[TBL] [Abstract][Full Text] [Related]
39. Sensitivity of [11C]phenylephrine kinetics to monoamine oxidase activity in normal human heart.
Raffel DM; Corbett JR; del Rosario RB; Mukhopadhyay SK; Gildersleeve DL; Rose P; Wieland DM
J Nucl Med; 1999 Feb; 40(2):232-8. PubMed ID: 10025828
[TBL] [Abstract][Full Text] [Related]
40. Radiolabeled phenethylguanidines: novel imaging agents for cardiac sympathetic neurons and adrenergic tumors.
Raffel DM; Jung YW; Gildersleeve DL; Sherman PS; Moskwa JJ; Tluczek LJ; Chen W
J Med Chem; 2007 May; 50(9):2078-88. PubMed ID: 17419605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
